Brian Markison
Also at Lantheus Holdings Inc
About
Brian Markison has built an impressive career in the pharmaceutical and healthcare industries over the past 40 years, demonstrating extensive expertise in operational management, marketing, and commercial development. His solid academic foundation, highlighted by earning a Bachelor of Science degree, has been complemented by hands-on leadership roles at prominent organizations in the sector.
Throughout his career, he has taken on progressively important roles, serving in senior positions at companies such as Bristol-Myers Squibb, King Pharmaceuticals, Fougera Pharmaceuticals, and RVL Pharmaceuticals. His experience ranges from leading product introductions to executing strategic operational initiatives, positioning him as a notable figure in the industry.
At LNTH, his journey has been marked by significant milestones. Initially joining the Board of Directors in September 2012, he advanced to Chairperson in January 2013 and ultimately assumed the role of Chief Executive Officer on March 1, 2024. His contributions in steering the company’s strategy and overseeing a smooth leadership transition underscore his dedication to fostering growth and innovation within the organization.
$LNTH Performance Under Brian Markison
Past Roles
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Lantheus Holdings (LNTH) | Executive Chairman | January 23, 2024 – March 1, 2024 | Served until his appointment as CEO |
| Lantheus Holdings (LNTH) | Non-Executive Chairman of the Board | September 2012 – January 23, 2024 | Joined Board in September 2012 and elevated to Chairman in January 2013 |
| Fougera Pharmaceuticals Inc. | President and Chief Executive Officer | N/A | Company was sold to Sandoz, the generics division of Novartis AG |
| King Pharmaceuticals | Chief Operating Officer, President, Chief Executive Officer, and Chairman | 2004 – N/A | Joined as COO in March 2004, promoted to President and CEO later in 2004, and elected Chairman in 2007 |
| Bristol-Myers Squibb | Various Senior Leadership Positions | N/A | Held roles including President of Oncology, Virology, and Oncology Therapeutics Network; President of Neuroscience, Infectious Disease, and Dermatology; and Senior Vice President, Operational Excellence and Productivity |
External Roles
| Organization | Role | Date Range | Details |
|---|---|---|---|
| RVL Pharmaceuticals plc | Chief Executive Officer and Director | Current | |
| The College of New Jersey | Director | Current | |
| Cosette Pharmaceuticals | Board Member | Current |